NO873216L - Rekombinante htlv-iii-proteiner og anvendelse derav. - Google Patents

Rekombinante htlv-iii-proteiner og anvendelse derav.

Info

Publication number
NO873216L
NO873216L NO873216A NO873216A NO873216L NO 873216 L NO873216 L NO 873216L NO 873216 A NO873216 A NO 873216A NO 873216 A NO873216 A NO 873216A NO 873216 L NO873216 L NO 873216L
Authority
NO
Norway
Prior art keywords
iii proteins
recombinant htlv
htlv
recombinant
proteins
Prior art date
Application number
NO873216A
Other languages
English (en)
Other versions
NO873216D0 (no
Inventor
Scott D Putney
Debra Lynn
Kashayar Javaherian
William Thomas Mueller
John Farley
Original Assignee
Repligen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Repligen Corp filed Critical Repligen Corp
Publication of NO873216D0 publication Critical patent/NO873216D0/no
Publication of NO873216L publication Critical patent/NO873216L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO873216A 1986-08-01 1987-07-31 Rekombinante htlv-iii-proteiner og anvendelse derav. NO873216L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US89268086A 1986-08-01 1986-08-01

Publications (2)

Publication Number Publication Date
NO873216D0 NO873216D0 (no) 1987-07-31
NO873216L true NO873216L (no) 1988-02-02

Family

ID=25400352

Family Applications (1)

Application Number Title Priority Date Filing Date
NO873216A NO873216L (no) 1986-08-01 1987-07-31 Rekombinante htlv-iii-proteiner og anvendelse derav.

Country Status (11)

Country Link
EP (2) EP0525828A3 (no)
JP (1) JPS6341499A (no)
KR (1) KR960005181B1 (no)
AU (1) AU609725B2 (no)
DK (1) DK400287A (no)
FI (1) FI873315L (no)
IL (1) IL83347A0 (no)
NO (1) NO873216L (no)
NZ (1) NZ221227A (no)
PT (1) PT85461B (no)
ZA (1) ZA875633B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166050A (en) * 1986-08-20 1992-11-24 Bristol-Myers Squibb Company Monoclonal antibodies and peptides useful in treating and diagnosing HIV infections
NZ221440A (en) * 1986-08-20 1991-11-26 Genetic Systems Corp Composition containing monoclonal antibodies/peptides useful in treating and diagnosing hiv infections
US5019387A (en) * 1987-09-08 1991-05-28 Duke University Production of antibodies to HIV
NO881501L (no) * 1987-10-09 1989-04-10 Repligen Corp Rekombinante htlv-111-proteiner og anvendelser av disse.
EP0311228A3 (en) * 1987-10-09 1990-05-02 Repligen Corporation Recombinant polypeptides and their uses, including assay for aids virus
US5763160A (en) * 1988-02-12 1998-06-09 United Biomedical, Inc. Synthetic peptides and process of using same for the detection of antibodies to human immunodeficiency virus (HIV) gp120 envelope protein, diagnosis of AIDS and pre-AIDS conditions and as vaccines
US5914109A (en) * 1990-06-15 1999-06-22 New York University Heterohybridomas producing human monoclonal antibodies to HIV-1
IL98845A0 (en) * 1990-07-19 1992-07-15 Merck & Co Inc Coconjugate vaccines comprising immunogenic protein,hiv related peptides,and anionic moieties,their preparation and pharmaceutical compositions containing them
US6228608B1 (en) * 1991-02-28 2001-05-08 Aquila Biopharmaceuticals, Inc. Recombinant FIV glycoprotein 160 and P24 gag protein
ES2260754T3 (es) 1992-06-18 2006-11-01 Creagen, Inc. Metodo para producir un conjunto de antigenos polipeptidicos combinatorios.
US5274122A (en) * 1992-10-15 1993-12-28 Merck & Co., Inc. Acidic derivatives of homocysteine thiolactone
WO1994014068A1 (en) * 1992-12-15 1994-06-23 Empyrean Diagnostics Inc. Hiv analysis method and device
DE4405810A1 (de) 1994-02-23 1995-08-24 Behringwerke Ag Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8423659D0 (en) * 1984-09-19 1984-10-24 Pasteur Institut Cloned dna sequences
IL76082A (en) * 1984-08-22 1991-07-18 Us Health Molecular clones of the genome of htlv-iii and a process for the preparation thereof
US9328391B1 (en) * 1984-08-22 2016-05-03 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Cloning and expression of HIV-1 DNA
KR930000189B1 (ko) * 1984-10-18 1993-01-11 앵스뛰띠 빠스뙤르 임파선증과 후천성 면역 결핍증 바이러스의 항원을 제조하는 방법 및 이 항원에 대한 항체의 생산 방법
CA1341482C (en) * 1984-10-31 2005-05-10 Paul A. Luciw Process for preparing fragments of aids-associated retroviruses
US4725669A (en) * 1984-11-09 1988-02-16 President And Fellows Of Harvard College Assay for detecting infection by human T-cell lymphotropic virus-III
ATE138100T1 (de) * 1984-12-24 1996-06-15 Genentech Inc Fusionen von aids-verwandten polypeptiden
US4774175A (en) * 1985-03-01 1988-09-27 Centocor, Inc. Immunochemical methods for the detection of antibody against HTLV-III
IE64785B1 (en) * 1985-04-08 1995-09-06 Genetic Systems Corp Expression of immunologically reactive viral proteins
DK171119B1 (da) * 1985-04-19 1996-06-17 Hoffmann La Roche AIDS-viruskappeprotein, ekspressionsvektor bærende viruskappeproteinet, transformanter transformeret med ekspressionsvektoren, fremgangsmåde til fremstilling af viruskappeproteinet, fremgangsmåde til detektion af AIDS-antistoffer, fremgangsmåde til bestemmelse af AIDS-virus, vaccine mod AIDS, antistoffer mod viruskappeproteinet samt anvendelse af dette til fremstilling af en vaccine og til testnin
EP0212532A1 (en) * 1985-08-12 1987-03-04 Syntex (U.S.A.) Inc. Method for producing fusion proteins
EP0227169B1 (en) * 1985-12-17 1993-03-17 Akzo N.V. Immunochemical reagent
US4734362A (en) * 1986-02-03 1988-03-29 Cambridge Bioscience Corporation Process for purifying recombinant proteins, and products thereof
EP0269712A4 (en) * 1986-06-12 1990-06-26 Biogen Nv PEPTIDES INVOLVED IN THE PATHOGENESIS OF A HIV TYPE INFECTION.
WO1988000471A1 (en) * 1986-07-21 1988-01-28 Southwest Foundation For Biomedical Research Composition of matter and method of immunizing against viral causative agents of aids and arc

Also Published As

Publication number Publication date
NO873216D0 (no) 1987-07-31
IL83347A0 (en) 1987-12-31
KR880003004A (ko) 1988-05-13
KR960005181B1 (ko) 1996-04-22
ZA875633B (en) 1988-10-26
AU609725B2 (en) 1991-05-09
FI873315A7 (fi) 1988-02-02
EP0525828A2 (en) 1993-02-03
JPS6341499A (ja) 1988-02-22
FI873315L (fi) 1988-02-02
EP0255190A2 (en) 1988-02-03
NZ221227A (en) 1990-07-26
PT85461B (pt) 1990-07-31
DK400287D0 (da) 1987-07-31
EP0525828A3 (en) 1993-02-24
AU7635887A (en) 1988-02-04
DK400287A (da) 1988-04-27
PT85461A (en) 1987-08-01
EP0255190A3 (en) 1990-08-29
FI873315A0 (fi) 1987-07-29

Similar Documents

Publication Publication Date Title
NO871409D0 (no) Fusjonsprotein.
FI874819L (fi) Human rekombinant endotelcell vaextfaktor.
DK122687A (da) Polypeptid, dna og anvendelse deraf
FI874287A7 (fi) Uudet lymfokiinipeptidit.
NO882917L (no) Fusjonsproteiner og partikler.
DK353788A (da) Polypeptidderivater
NO873216D0 (no) Rekombinante htlv-iii-proteiner og anvendelse derav.
DK551287A (da) Polypeptid
DK354487A (da) Oncogen-relaterede peptider
DK531986D0 (da) Peptider
DK413187A (da) Semicarbazoner og thiosemicarbazoner
DK451786D0 (da) Transglucosidase, fremstilling og anvendelse deraf
DK196088D0 (da) Rekombinant htlv-iii protein og anvendelse deraf
DK345087D0 (da) Protein
DK698188A (da) Peptider, deres fremstilling og anvendelse
FI864626L (fi) Rekombinantricintoxin.
FI893450L (fi) Modifierade proteiner.
NO882709D0 (no) Nye peptider og anvendelse derav.
NO875477D0 (no) Rekombinant alveolaert overflateaktivt protein.
NO904846D0 (no) Amfifile peptider og anvendelse derav.
NO881501D0 (no) Rekombinante htlv-111 proteiner og anvendelse av disse.
NO883697L (no) Nytt pertussis toxin-avledet polypeptid og anvendelse derav.
IS3300A7 (is) Ný fjölpeptíð og notkun þeirra.
DK376187D0 (da) Peptider
DK434986D0 (da) Peptider